Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
about
Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells.GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.Skeletal muscle generated from induced pluripotent stem cells - induction and application.Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors.The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology.Zika virus directly infects peripheral neurons and induces cell death.Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic ProgenitorsReversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.Myogenic progenitor specification from pluripotent stem cells.ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.Engineering human pluripotent stem cells into a functional skeletal muscle tissue.Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture.Current Progress and Challenges for Skeletal Muscle Differentiation from Human Pluripotent Stem Cells Using Transgene-Free Approaches.Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies.Generation of Functional Myocytes from Equine Induced Pluripotent Stem Cells
P2860
Q30837631-8061D663-C9C1-4634-A09C-839B263233DEQ33635336-E5C5DF97-A364-49D2-88D5-08BCFE55341AQ33854768-AC6482C4-FE53-48D7-990D-D24C84434E53Q33905388-27982D3A-CB08-489E-A72C-84E117BBCBE1Q37666286-3B20415B-42A5-4ADC-B2D5-20A14FA0BFDEQ38157211-B0D43DEA-1E58-4476-BF01-CEC181E2AE98Q39368114-93032665-0E88-45DA-A376-6F681071DF5DQ41131888-573FA97F-04D6-4BA7-A6F1-F1BB68438B65Q45875854-E2B47396-BEC6-4045-8048-20BF391D9301Q47286671-4B7FE97B-92A3-48FD-8433-8D27C8F10007Q48097715-87BB7386-701F-40A4-83CA-C7E808DFF57EQ49165157-3514B834-AF8A-4164-8AAF-7D6A410BAA96Q50067732-42082F01-EAD8-409B-B1B9-0831D01855B7Q54987739-B3B7DDC0-05CC-4E2C-A984-843EEB72067FQ55032494-6636541E-27F4-423B-8306-B176E331D704Q59128341-D3179D1E-24F4-4996-9213-4EF0278BF1B1
P2860
Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@en
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@nl
type
label
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@en
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@nl
prefLabel
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@en
Concordant but Varied Phenotyp ...... sing a Human iPSC-Based Model.
@nl
P2093
P50
P1433
P1476
Concordant but Varied Phenotyp ...... using a Human iPSC-Based Model
@en
P2093
Christopher J Donnelly
Hongmei Lisa Li
Hyesoo Kim
In Young Choi
Jeffrey Rothstein
Jyothi Mula
Kathryn R Wagner
Kenneth Estrellas
Mitsuo Oshimura
P304
P356
10.1016/J.CELREP.2016.05.016
P577
2016-05-26T00:00:00Z